Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8187824 | Porphyrinic compounds for use in flow cytometry The present invention provides a method of detecting (e.g., by flow cytometry) a target compound, cell or particle, wherein the target is labelled with a detectable luminescent compound. The method comprises utilizing as the detectable luminescent compound a compoun... | 05/29/2012 |
| 8188268 | Porous crystalline saccharide, its preparation and uses An object of the present invention is to provide a crystalline saccharide having novel physical properties, a preparation and uses thereof. The present invention solves the above objects by providing a porous crystalline saccharide having a number of pores, a proces... | 05/29/2012 |
| 8188266 | Cellulose- or lignocellulose-containing composite materials based on a silane-based composite as a binder The present invention relates to a composite material based on (a) a cellulose- or lignocellulose-containing material and (b) a composite as a binder, the composite resulting from the reaction of at least the components (i) a glycidyloxypropylalkoxysilane, (ii) an a... | 05/29/2012 |
| 8183290 | Pharmaceutically acceptable propylene glycol solvate of naproxen The invention relates to pharmaceutical compositions comprising propylene glycol solvates of APIs. In particular a 2:1 complex of naproxen sodium to propylene glycol is disclosed which is a crystalline solid. The complex is prepared by crystallization of a mixture o... | 05/22/2012 |
| 8183228 | Anticoagulant antithrombotic dual inhibitors comprising a biotin label The present invention relates compounds of the formula: oligosaccharide-spacer-(GpIIb/IIIa antagonist), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units, the charge being compensated by p... | 05/22/2012 |
| 8178663 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring The present invention relates to hyaluronic acid ester derivatives, whose carboxylic groups are partially esterified with hydroxy groups of propiophenone derivatives, to the hydrogel materials consisting of the said hyaluronic acid ester derivatives, to their prepar... | 05/15/2012 |
| 8178511 | Method of administering hyaluronan formulation for the amelioration of osteopenia Disclosed is a method for the amelioration of resorptive bone loss in osteopenia including administering to a subject a therapeutically effective amount of an exogenous hyaluronan formulation. ... | 05/15/2012 |
| 8178501 | Antibiotic combinations for providing total solution to the treatment of infections The invention relates to a new pharmaceutical composition, a method of treatment of infection and also a process to prepare the composition. The infectious complications are important causes of morbidity and mortality. Hospital acquired pneumonia (HAP) remains the m... | 05/15/2012 |
| 8178499 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring The present invention relates to hyaluronic acid ester derivatives, whose carboxylic groups are partially esterified with hydroxy groups of propiophenone derivatives, to the hydrogel materials consisting of the said hyaluronic acid ester derivatives, to their prepar... | 05/15/2012 |
| 8173607 | Promoter for the production of hyaluronic acid containing ginsenoside compound K There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (compound K), a chief metabolite of ginseng saponin, to increase the expres... | 05/08/2012 |
| 8173843 | Amphiphilic derivatives of α-C-phenyl--butylnitrone Compounds derived from α-C-phenyl-N-tert-butylnitrone, a process for the preparation thereof and use thereof for the preparation of medicaments for use in preventing or treating oxidative stress-related diseases. ... | 05/08/2012 |
| 8173799 | Raw cotton linters composition, method of making, and uses thereof A composition of a loose mass of comminuted raw cotton linter fibers has a bulk density of at least 8 g/100 ml and at least 50% of the fibers in the mass passes through a US standard sieve size #10 (2 mm opening). This composition is made by obtaining a loose mass o... | 05/08/2012 |
| 8173606 | Sulfated oligosaccharide derivatives The invention relates to compounds which are polysulfated oligosaccharide derivatives having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; methods for the preparation of the compounds; compositions comprising the... | 05/08/2012 |
| 8168778 | Highly-branched starch, its production and uses An object of the present invention is to provide a novel starchy substance having a retrogradation-resistance, a process for producing the starchy substance efficiently from a material starch by enzymatic reaction, and uses thereof. The present invention attains the... | 05/01/2012 |
| 8168779 | Anhydrous crystalline β-maltose, its preparation and uses Objects of the present invention are to provide a novel anhydrous crystalline β-maltose, its preparation and uses. The present invention attains the above objects by providing an anhydrous crystalline β-maltose with a melting point of 154 to 159° C.; a process fo... | 05/01/2012 |
| 8168599 | Composition and method for healing tissues The composition and method for healing tissues is a medicinal composition for facilitating the growth, protection and healing of tissues and cells in animals and humans. The composition is formulated as a either a powder, gel, paste, film, fluid injectable, rehydrat... | 05/01/2012 |
| 8168595 | Antithrombotic dual inhibitors comprising a biotin residue The present invention relates to compounds of the formula (I) oligosaccharide-spacer-A (1), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising two to twenty five monosaccharide units, the charge being compensated by positively cha... | 05/01/2012 |
| 8168598 | Optimised formulation of tobramycin for aerosolization The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatmen... | 05/01/2012 |
| 8163714 | Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery The invention relates to the use of implantable microcapsules, or microparticles or gels produced from alginates that are crosslinked with bivalent or multivalent cations or that are uncrosslinked, for the treatment of skin defects such as e.g. wrinkles, for the tre... | 04/24/2012 |
| 8158608 | Bioactive fraction from and a process for the preparation thereof Ulcer is a serious oxidative stress induced disease with complex pathologic events including upregulation of H+K+ ATPase of parietal cell (PC) membrane, damage of mucin layer around PC, PC-DNA damage etc. The polysaccharide (GRPP) fraction and ... | 04/17/2012 |
| 8158610 | Dextrin-containing composition for preventing surgical adhesions A method of reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin. | 04/17/2012 |
| 8158609 | Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen The present invention is directed to the treatment of disorders involving the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy via administration of therapeutically effective amounts of at least one monomeric or polymeric c... | 04/17/2012 |
| 8158778 | Method for the desalting of saccharide solution and an anion exchanger The present invention provides the means for suppressing the production of decomposition reactant, isomerization reactant, colored material, and so on when a saccharide solution is desalted, thereby suppressing the production of impurities and preventing coloration ... | 04/17/2012 |
| 8153782 | Reformation of ionic liquids Processes for recycling an ionic liquid comprising employing an initial ionic liquid as a solvent and/or reagent resulting in a modified ionic liquid and thereafter subjecting at least a portion of the modified ionic liquid to at least one anion exchange process to ... | 04/10/2012 |
| 8153601 | Azithromycin-containing aqueous pharmaceutical composition and a method for the preparation of the same The invention provides an azithromycin-containing aqueous pharmaceutical composition, which comprises at least one member selected from the group consisting of azithromycin, and pharmaceutically acceptable salts thereof, and at least one member selected from the gro... | 04/10/2012 |
| 8153135 | Polysaccharide-polypeptide conjugate Disclosed is a method of producing a polysaccharide-polypeptide conjugate by reacting a polysaccharide with a polypeptide which contains at least one free amino group, wherein a polysaccharide carrier comprising vicinal hydroxyl groups is oxidized under ring opening... | 04/10/2012 |
| 8153610 | Sulfoglycolipid antigens, their extraction from , and their use against tuberculosis The present invention relates to compounds of the following general formula: (I) wherein R1 and R2 are fatty acyl groups, a process to extract them from Mycobacterium tuberculosis, and their use in the treatment or the prophylaxis of tub... | 04/10/2012 |
| 8153600 | Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and ... | 04/10/2012 |
| 8148518 | Cellulose esters and their production in carboxylated ionic liquids Ionic liquids and cellulose ester compositions and processes and apparatus for producing ionic liquids and cellulose esters. Cellulose esters can be produced by dissolving cellulose in carboxylated ionic liquids and thereafter contacting the cellulose solution with ... | 04/03/2012 |
| 8148348 | Method of stabilizing S-adenosyl-L-methionine and stabilized composition Provided are a process for producing a S-adenosyl-L-methionine-containing composition which is very excellent in a stability by adding at least ascorbic acids or salts thereof to a composition liquid containing S-adenosyl-L-methionine and then drying the above compo... | 04/03/2012 |
| 8148504 | Aminoglycoside antibiotics This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the ... | 04/03/2012 |
| 8148517 | Phosphorylated waxy potato starch The invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and a content of side chains having a DP of from 12 to 19 which is e... | 04/03/2012 |
| 8148350 | Carbohydrate composition for flat glucose response A low-glycemic available carbohydrate composition of the invention contains the following components: (i) 5-60 wt. % of one or more monosaccharides selected from monosaccharides other than glucose and fructose, in particular galactose, ribose and mannos... | 04/03/2012 |
| 8143391 | Process for producing water-soluble hyaluronic acid modification The present invention provides a water-soluble modified HA practically used as a drug carrier and a production method thereof. The present invention provides: a water-soluble modified hyaluronic acid, the residence time in blood of which is elongated to a practical ... | 03/27/2012 |
| 8143226 | Tyrosine kinase receptor antagonists and methods of treatment for breast cancer A method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors wh... | 03/27/2012 |
| 8137685 | Hyaluronic acid compound, hydrogel thereof and joint treating material A hyaluronic acid compound which is a reaction product between hyaluronic acid and a phosphatidyl ethanolamine. This compound has biocompatibility and bio-safety, and can be formed into a hydrogel or molded form having a certain shape. Making use of these properties... | 03/20/2012 |
| 8138162 | Natural sweetener The invention relates to extracts, in particular non-nutrient phytochemicals, form sugar cane or sugar beet waste products, such as molasses, sugar mud and bagasse, which have Glycemic Index (GI) lowering properties and their use as sweeteners and in foods containin... | 03/20/2012 |
| 8138331 | Water-dispersible polysaccharide derivatives of reduced glyoxal content, and a process for decreasing the glyoxal content in glyoxal-crosslinked polysaccharide derivatives A description is given of glyoxal-treated polysaccharide derivatives which, to decrease the unbound glyoxal, are treated with an aqueous solution of one or more water-soluble aluminium salts, or one or more water-soluble borates, or a combination of one or more wate... | 03/20/2012 |
| 8133990 | 6-position highly acetylated cellulose diacetate and process for producing the same Disclosed is a cellulose diacetate comprising a 6-position highly acetylated cellulose diacetate having a 6-percent viscosity of 40 to 600 mPa·s, and having a total degree of acetyl substitution of DSt and a degree of acetyl substitution at the 6-position of DS6, w... | 03/13/2012 |
| 8133991 | Allergen inactivating agent An allergen inactivating agent is provided which has no adverse effects on the human body and which does not cause problems such as color development. An allergen inactivating agent containing a polysaccharide derivative as its effective component, wherein sa... | 03/13/2012 |
